Check out our most popular compounded medications! Get Started
The 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to provide a controlled and prolonged release of the active ingredient, 5-Hydroxytryptophan. This is achieved through the use of Methocel E4M, a controlled-release polymer that ensures the gradual release of the medication over an extended period of time.
This formulation offers sustained therapeutic effects, reducing the need for frequent dosing and thereby improving patient compliance. It is particularly beneficial for patients requiring a steady and prolonged supply of 5-Hydroxytryptophan to manage their disease states.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
The 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules are a specially formulated medication designed to provide a controlled and prolonged release of the active ingredient, 5-Hydroxytryptophan (5-HTP). This formulation utilizes Methocel E4M, a type of controlled-release polymer, to gradually release the encapsulated 5-HTP over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance, making it an ideal choice for medications requiring a controlled release profile.
5-HTP is a naturally occurring amino acid and a chemical precursor to serotonin, a neurotransmitter that plays a crucial role in mood regulation, sleep, appetite, and pain sensation. As such, this formulation is commonly used in the treatment of various disease states related to serotonin deficiency or imbalance. These include depression, anxiety, insomnia, and certain types of chronic pain. By providing a steady and prolonged release of 5-HTP, this formulation helps to maintain optimal serotonin levels in the body, thereby alleviating the symptoms associated with these conditions.
It's important to note that while 5-HTP is generally well-tolerated, it may interact with certain medications, particularly those used to treat depression and migraines. Therefore, it's crucial for patients to inform their healthcare provider of all medications they are currently taking before starting this treatment. Side effects may include nausea, diarrhea, and, in rare cases, serotonin syndrome, a potentially life-threatening condition characterized by agitation, hallucinations, rapid heartbeat, and high body temperature.
As compounding pharmacists, we are committed to providing high-quality, personalized medications to meet the unique needs of each patient. We encourage both patients and prescribers to reach out to us with any questions or concerns regarding this formulation. We are here to provide the necessary information and support to ensure the safe and appropriate use of our compounded medications.
5-Hydroxytryptophan (5-HTP) is a naturally occurring amino acid and a precursor to the neurotransmitter serotonin. It is often used in the treatment of various conditions such as depression, anxiety, insomnia, and fibromyalgia. However, like all medications, 5-HTP can interact with other drugs, potentially altering their effects or increasing the risk of side effects.
One of the most significant interactions to be aware of is with antidepressant medications, particularly those that increase serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs) and monoamine oxidase inhibitors (MAOIs). Combining 5-HTP with these medications can lead to a potentially life-threatening condition called serotonin syndrome, characterized by symptoms such as agitation, hallucinations, rapid heartbeat, fever, and changes in blood pressure.
5-HTP may also interact with drugs used for Parkinson's disease, such as carbidopa. This combination can cause a scleroderma-like condition, a rare but serious illness that affects the skin and internal organs. Therefore, it is crucial to avoid this combination unless under the strict supervision of a healthcare provider.
Other potential interactions include sedative medications (CNS depressants) and triptans used for migraines. Combining 5-HTP with these drugs may increase their sedative effects or potentially cause serotonin syndrome, respectively.
It's important to note that the slow-release formulation of 5-HTP may alter the timing and intensity of these interactions. Methocel E4M, the controlled-release polymer used in this formulation, is designed to gradually release the active ingredient over an extended period. This may reduce the risk of side effects and improve the medication's overall safety profile. However, it could also potentially delay the onset of drug interactions, making them less predictable.
As a patient or prescriber, it's crucial to be aware of these potential interactions and monitor for any signs of adverse effects. Always inform your healthcare provider of all medications, supplements, and herbal products you are taking before starting a new treatment.
If you have any questions about this formulation or its potential interactions, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is always here to provide the information and support you need.
The 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules work by utilizing a controlled-release polymer known as Methocel E4M. This polymer is designed to gradually release the encapsulated medication or active ingredient over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
5-Hydroxytryptophan, also known as 5-HTP, is a naturally occurring amino acid and a chemical precursor to the neurotransmitter serotonin. Serotonin plays a crucial role in regulating mood, anxiety, sleep, and a variety of other physiological processes. By providing a slow, steady supply of 5-HTP, these capsules help to maintain optimal levels of serotonin in the brain, which can help to alleviate symptoms associated with conditions such as depression, anxiety, insomnia, and certain types of chronic pain.
The slow-release formulation of these capsules is particularly beneficial for conditions that require long-term management, as it ensures a consistent level of medication in the body throughout the day and night. This can help to prevent the peaks and troughs in medication levels that can occur with immediate-release formulations, leading to more stable symptom control and fewer side effects.
As always, patients should discuss their symptoms and treatment options with their healthcare provider to determine the best course of action for their individual needs.
If you have any questions about the 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules, or any other aspect of your medication, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
The key component of these capsules is 5-Hydroxytryptophan (50 mg), formulated with Methocel E4M. Methocel E4M acts as a controlled-release polymer designed to gradually release the active ingredient over an extended period of time.
Methocel E4M is used in these capsules due to its controlled-release properties. It aids in the gradual release of the medication, offering sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications that require a controlled and prolonged release profile.
A controlled-release formulation like this one reduces the amount of doses a patient needs to take, improves patient compliance by making the treatment easier to follow, and provides a sustained therapeutic effect over a longer period of time.
The main therapeutic effect of 5-Hydroxytryptophan is to help maintain mood balance and support relaxation. The slow-release action of these capsules aids in maintaining these effects over a long period of time.
In general, these capsules can be safely used over a long-term basis, although individual responses can vary. It's always advised to consult with a healthcare provider for personalized advice regarding long-term use.
Yes, you typically need a prescription to purchase medications like the 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules, and it's always best to use them under the supervision of a healthcare provider due to potential side effects and contraindications with other medications.
If you miss a dose of this medication, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses unless directed by your healthcare provider.
As with all medicines, these capsules may have the potential for side effects. Some common side effects may include nausea, stomach pain, and sleep disturbances. If any unusual side effects occur, do contact a healthcare professional.
The interaction of these capsules with other medications depends on the specific medication in question. To ensure safety, discuss with your healthcare provider about any medications you are currently taking before starting this medicine.
Pregnant or breastfeeding women should consult a healthcare provider before starting any new medication, including the 5-Hydroxytryptophan 50 mg Slow Release (MEM4) Oral Capsules, to ensure the safety of the mother and the baby.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
